| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
20,640 |
19,137 |
$2.36M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
16,407 |
15,006 |
$1.99M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
11,605 |
10,358 |
$1.54M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,889 |
1,615 |
$504K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,584 |
1,377 |
$365K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,216 |
1,138 |
$349K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,155 |
883 |
$325K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,633 |
2,241 |
$257K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
718 |
614 |
$184K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,051 |
824 |
$179K |
| 80053 |
Comprehensive metabolic panel |
16,093 |
14,301 |
$126K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
510 |
438 |
$124K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
963 |
870 |
$119K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
979 |
714 |
$112K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,301 |
395 |
$106K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
12,740 |
10,426 |
$77K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
731 |
605 |
$69K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
2,505 |
777 |
$60K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
492 |
426 |
$59K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
453 |
418 |
$55K |
| G0378 |
Hospital observation service, per hour |
898 |
406 |
$50K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
197 |
139 |
$49K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
320 |
315 |
$44K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
447 |
163 |
$34K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
915 |
810 |
$34K |
| 97162 |
|
518 |
460 |
$32K |
| 71046 |
Radiologic examination, chest; 2 views |
2,268 |
2,098 |
$30K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,152 |
1,875 |
$28K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,464 |
4,548 |
$27K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,348 |
1,943 |
$27K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
22,589 |
19,540 |
$26K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
899 |
795 |
$22K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
121 |
105 |
$22K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,964 |
8,003 |
$21K |
| 71045 |
Radiologic examination, chest; single view |
6,433 |
5,728 |
$21K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,525 |
2,326 |
$21K |
| 36415 |
Collection of venous blood by venipuncture |
26,414 |
22,225 |
$21K |
| 88142 |
|
994 |
920 |
$20K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
99 |
86 |
$20K |
| 85027 |
|
1,896 |
1,682 |
$20K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
453 |
413 |
$18K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
533 |
459 |
$18K |
| 84484 |
|
4,646 |
3,933 |
$14K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,428 |
3,913 |
$14K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
451 |
413 |
$14K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
145 |
125 |
$13K |
| 80061 |
Lipid panel |
931 |
831 |
$13K |
| 84439 |
|
609 |
544 |
$12K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
3,435 |
3,221 |
$12K |
| 86900 |
|
578 |
473 |
$11K |
| 59025 |
Fetal non-stress test |
62 |
38 |
$11K |
| 86850 |
|
572 |
473 |
$10K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
376 |
337 |
$10K |
| 74018 |
|
285 |
246 |
$8K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
301 |
260 |
$8K |
| 72100 |
|
250 |
220 |
$8K |
| 86803 |
|
318 |
287 |
$8K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
42 |
39 |
$7K |
| J3490 |
Unclassified drugs |
458 |
309 |
$7K |
| 84702 |
|
457 |
310 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
561 |
496 |
$6K |
| 80320 |
|
420 |
329 |
$6K |
| 81001 |
|
12,566 |
11,418 |
$6K |
| 96367 |
|
94 |
65 |
$6K |
| 73630 |
|
364 |
327 |
$5K |
| 71250 |
|
72 |
65 |
$5K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,259 |
4,465 |
$4K |
| 86703 |
|
96 |
80 |
$4K |
| 73562 |
|
249 |
216 |
$4K |
| 73030 |
|
213 |
180 |
$4K |
| 87088 |
|
1,167 |
973 |
$4K |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
92 |
79 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,602 |
6,639 |
$4K |
| 76642 |
|
28 |
25 |
$4K |
| 73130 |
|
236 |
201 |
$3K |
| 82607 |
|
193 |
172 |
$3K |
| 86901 |
|
600 |
489 |
$3K |
| 87340 |
|
132 |
124 |
$3K |
| 87077 |
|
606 |
520 |
$3K |
| 76830 |
Ultrasound, transvaginal |
102 |
93 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,045 |
1,787 |
$3K |
| 85610 |
|
1,471 |
1,193 |
$3K |
| 73610 |
|
261 |
242 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,543 |
2,871 |
$3K |
| 86140 |
|
2,070 |
1,820 |
$2K |
| 12001 |
|
12 |
12 |
$2K |
| 83735 |
|
1,634 |
1,272 |
$2K |
| 80143 |
|
490 |
392 |
$2K |
| 83605 |
|
1,396 |
1,170 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
226 |
178 |
$2K |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
97 |
91 |
$2K |
| 87186 |
|
545 |
472 |
$2K |
| 86780 |
|
91 |
76 |
$2K |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
102 |
71 |
$2K |
| 83540 |
|
155 |
141 |
$2K |
| 83550 |
|
117 |
107 |
$2K |
| 83690 |
|
4,419 |
3,894 |
$2K |
| 73110 |
|
124 |
110 |
$2K |
| 82077 |
|
274 |
216 |
$2K |
| 81025 |
|
2,692 |
2,332 |
$2K |
| 72040 |
|
30 |
27 |
$1K |
| 93971 |
|
15 |
14 |
$1K |
| 83880 |
|
659 |
536 |
$1K |
| 76536 |
|
12 |
12 |
$1K |
| 86762 |
|
54 |
51 |
$1K |
| 87081 |
|
1,201 |
1,164 |
$1K |
| 87040 |
|
812 |
639 |
$1K |
| 90715 |
|
73 |
68 |
$1K |
| 86592 |
|
72 |
72 |
$1K |
| 80179 |
|
472 |
379 |
$1K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
29 |
26 |
$1K |
| 82150 |
|
2,429 |
2,191 |
$1K |
| 82947 |
|
1,037 |
651 |
$1K |
| 85379 |
|
1,737 |
1,524 |
$986.63 |
| 97161 |
|
14 |
14 |
$904.29 |
| 82248 |
|
839 |
706 |
$862.82 |
| 80076 |
|
290 |
252 |
$851.49 |
| 82728 |
|
48 |
44 |
$826.99 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
65 |
53 |
$740.89 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
691 |
634 |
$738.60 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,696 |
3,860 |
$641.87 |
| 96376 |
|
392 |
270 |
$617.82 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,761 |
1,709 |
$588.79 |
| 82746 |
|
48 |
44 |
$570.12 |
| 82570 |
|
65 |
54 |
$503.41 |
| 87634 |
|
196 |
161 |
$439.15 |
| 84144 |
|
19 |
12 |
$418.70 |
| 82803 |
|
363 |
292 |
$398.72 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
953 |
750 |
$315.41 |
| 85652 |
|
57 |
51 |
$305.66 |
| 81003 |
|
1,002 |
877 |
$294.44 |
| 80305 |
|
69 |
64 |
$293.36 |
| 85730 |
|
1,163 |
994 |
$232.19 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,943 |
4,329 |
$224.46 |
| 87070 |
|
31 |
26 |
$183.45 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
822 |
593 |
$179.20 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
694 |
498 |
$173.02 |
| 73502 |
|
12 |
12 |
$171.45 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
648 |
510 |
$144.90 |
| 84100 |
|
76 |
61 |
$122.22 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
454 |
385 |
$122.03 |
| 73080 |
|
17 |
16 |
$81.59 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
985 |
843 |
$76.88 |
| 84703 |
|
80 |
59 |
$74.76 |
| 84156 |
|
19 |
14 |
$66.32 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
246 |
187 |
$63.24 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
421 |
296 |
$31.66 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,332 |
1,794 |
$30.32 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
14 |
12 |
$26.88 |
| J2704 |
Injection, propofol, 10 mg |
570 |
456 |
$22.73 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
427 |
313 |
$22.46 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
100 |
85 |
$20.47 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
170 |
125 |
$19.48 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
15 |
12 |
$14.90 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
480 |
361 |
$10.57 |
| J7050 |
Infusion, normal saline solution, 250 cc |
148 |
111 |
$7.44 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
324 |
265 |
$6.60 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
283 |
208 |
$6.03 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
185 |
137 |
$5.90 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
41 |
25 |
$2.72 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
353 |
297 |
$2.72 |
| J2060 |
Injection, lorazepam, 2 mg |
31 |
26 |
$0.91 |
| J7510 |
Prednisolone oral, per 5 mg |
75 |
60 |
$0.26 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
90 |
82 |
$0.00 |
| 97116 |
|
15 |
12 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
69 |
55 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
20 |
16 |
$0.00 |
| 94664 |
|
19 |
15 |
$0.00 |
| 87807 |
|
41 |
40 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
51 |
35 |
$0.00 |
| 94760 |
|
21 |
13 |
$0.00 |